The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer

Jin-Zhi Xu, Wen-Quan Wang, Wu-Hu Zhang, Hua-Xiang Xu, He-Li Gao, Shi-Rong Zhang, Chun-Tao Wu, Shuo Li, Hao Li, Xianjun Yu, Liang LiuJournal of Cancer 2019 · DOI

Abstract

Pancreatic ductal adenocarcinoma (PDAC) progression is mediated by mutations in driver genes and a complex stroma that is mainly dependent on the Sonic hedgehog (Shh) signaling pathway. This study analyzed protein expressions of KRAS, TP53, SMAD4, and CDKN2A/P16 driver genes and Shh-pathway molecules (Shh, Gli1, Gli2, SMO) in 237 patients. SMAD4 loss was associated with significantly shorter survival. A strong correlation was found between SMAD4 loss and Shh/Gli1 expression. Patients with both SMAD4 loss and high Shh pathway activation showed the poorest survival outcomes, indicating that loss of SMAD4 associated with a strongly activated Shh pathway predicts poor prognosis in resected PDAC.

Introduction

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, largely due to its aggressive nature and a dense, fibrous "shield" called the stroma. This stroma is heavily influenced by the Sonic Hedgehog (Shh) signaling pathway. While scientists have identified four major "driver" gene mutations (KRAS, TP53, SMAD4, and CDKN2A/P16) that push PDAC progression, the crosstalk between these internal genetic mutations and the external Shh-driven stroma has remained a "black box." This study aims to bridge that gap, investigating how driver mutations correlate with Shh pathway activation and whether their combined status can better predict patient outcomes than looking at single markers alone.

Methodology

The researchers conducted a retrospective study of 237 patients who underwent surgery for PDAC at the Pancreatic Cancer Institute of Fudan University. They utilized tissue microarrays (TMAs) to organize small punches of tumor tissue for high-throughput analysis. Immunohistochemistry (IHC) was then performed to visualize the protein expression levels of the four driver genes and four key Shh pathway molecules (Shh, Gli1, Gli2, and SMO). Driver genes were categorized as "intact" or "lost/abnormal," while Shh pathway proteins were scored based on a formula combining the percentage of positive cells and staining intensity.

Representative immunohistochemical staining of pancreatic ductal adenocarcinoma tissues for driver genes and Shh pathway molecules.

Results

The analysis revealed that SMAD4 loss is a potent indicator of poor prognosis, associated with a nearly twofold increase in the risk of death (HR 1.887, p < 0.001) and recurrence (HR 1.886, p < 0.001). Furthermore, a significant correlation was found between SMAD4 loss and high expression levels of Shh (R = 0.343) and Gli1 (R = 0.505).

The most striking finding was the synergistic effect of these markers. Patients exhibiting both SMAD4 loss and a "strongly activated" Shh pathway (high Gli1 and SMO) experienced the poorest outcomes. Their Hazard Ratio for death was 3.598 compared to the low-risk group. The median overall survival for the low-risk group (intact SMAD4 + weak Shh) was 34.0 months, whereas the high-risk group (lost SMAD4 + strong Shh) survived only 9.0 months. Interestingly, while abnormal p53 staining also predicted poor overall survival, the status of p16 did not significantly impact survival in this cohort.

Discussion and Conclusion

These findings suggest that SMAD4 may function as a regulatory "brake" on the Hedgehog pathway. When SMAD4 is lost, the Shh pathway becomes hyper-activated, leading to a more aggressive tumor phenotype and a supportive stroma. This study highlights the importance of integrated prognostic models that consider both the genetic makeup of the cancer cell and the state of its microenvironment. Identifying high-risk subgroups through these combined markers could eventually guide more personalized therapeutic strategies, such as targeting the Shh pathway in patients with SMAD4-deficient tumors.

Summary updated

Abstract

<b>Background</b>: Pancreatic ductal adenocarcinoma (PDAC) progression is mediated by mutations in driver genes and a complex stroma that is mainly dependent on the Sonic hedgehog (Shh) signaling pathway. However, the association between driver genes and Shh-pathway proteins and their potential prognostic significance remain unclear. <b>Methods</b>: We analyzed protein expressions of the <i>KRAS, TP53, SMAD4</i>, and <i>CDKN2A/P16</i> driver genes and the Shh-pathway molecules, including Shh, glioma-associated oncogene (Gli) 1, Gli2, and smoothened (SMO) by immunohistochemistry using tissue microarrays in 237 patients with resectable PDAC and statistically determined their prognostic significance. <b>Results</b>: <i>SMAD4</i> <sup>lost</sup> mutation was associated with shorter survival outcomes [overall survival (OS): Hazard ratio (HR) 1.887, <i>p</i> < 0.001]; recurrence-free survival (RFS): HR 1.886, <i>p</i> < 0.001) and abnormal p53 immunolabeling was associated with poor OS (HR 1.436, <i>p</i> = 0.011) in patients with PDAC. The mutational status of p16 had no effect on patient survival. High levels of SMO and Gli1 expression were associated with poor survival outcomes in both univariate and multivariate analyses. Pearson's χ<sup>2</sup> test showed a medium correlation between the <i>SMAD4</i> <sup>lost</sup> mutation and Shh (R = 0.343) and Gli1 (R = 0.505) expression levels (<i>p</i> < 0.001). Patients with the <i>SMAD4</i> <sup>lost</sup> mutation and high levels of Shh and Gli1 expression showed the poorest survival outcomes (RFS: HR 2.976; OS: HR 3.598; <i>p</i> < 0.001 for both) compared with other patients in the study. <b>Conclusion</b>: Loss of <i>SMAD4</i> associated with a strongly activated Shh pathway resulted in poor survival outcomes in patients with resected PDAC.
BibTeX
@article{xu2019loss,
  author = {Jin-Zhi Xu and Wen-Quan Wang and Wu-Hu Zhang and Hua-Xiang Xu and He-Li Gao and Shi-Rong Zhang and Chun-Tao Wu and Shuo Li and Hao Li and Jin Xu and Xianjun Yu and Liang Liu},
  title = {{The Loss of <i>SMAD4/DPC4</i> Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer}},
  journal = {Journal of Cancer},
  year = {2019},
  doi = {10.7150/jca.30883},
}
Figure